Capital Research files Schedule 13G: 21.1M shares of GE HealthCare (GEHC)

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. — Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership of 21,114,633 shares of common stock, or 4.6% of the 456,290,143 shares believed to be outstanding. The amendment identifies sole voting power for 21,106,720 shares and sole dispositive power for 21,114,633. The filing is signed by a Capital Research officer on 05/11/2026.

Insights

Institutional Ownership Analyst

Large asset manager reports a sub-5% passive stake in GE HealthCare.

Capital Research Global Investors discloses a beneficial position of 21,114,633 shares, equal to 4.6% of the outstanding common stock as stated. The filing presents voting and dispositive power split, with nearly identical sole voting and dispositive counts.

Because the stake is below 5%, the filing is consistent with passive or investment-management reporting; further filings would disclose changes above regulatory thresholds.

Corporate Governance Specialist

Disclosure clarifies voting and disposition authority across affiliated entities.

The amendment explains that CRGI is a division of Capital Research and Management Company and lists affiliated investment management entities as part of the reporting group, which is standard for institutional filings. The filing attributes specific sole voting and dispositive powers to CRGI.

The filing does not state any change in board composition or agreements; subsequent Schedule 13D/13G amendments would be needed if ownership or intent changes materially.

Key Figures

Beneficial ownership: 21,114,633 shares Percent of class: 4.6% Sole voting power: 21,106,720 shares

3 metrics

Beneficial ownership 21,114,633 shares reported in Schedule 13G/A

Percent of class 4.6% of 456,290,143 shares believed outstanding

Sole voting power 21,106,720 shares sole power to vote as stated in filing

Key Terms

Schedule 13G/A, beneficial owner, sole dispositive power

3 terms

Schedule 13G/A regulatory

"Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficial owner financial

"CRGI is deemed to be the beneficial owner of 21,114,633 shares"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 21,114,633"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 10:19 AM Learn about SEC filing dates

FAQ

What stake does Capital Research Global Investors report in GE HealthCare (GEHC)?

Capital Research Global Investors reports beneficial ownership of 21,114,633 shares, representing 4.6% of the 456,290,143 shares the filing states are believed outstanding.

Who holds voting and dispositive power for the shares reported by CRGI?

The filing states CRGI has sole voting power for 21,106,720 shares and sole dispositive power for 21,114,633 shares, with no shared voting or dispositive power disclosed.

When was the Schedule 13G/A amendment signed?

The amendment is signed by Jae Won Chung, Vice President and Senior Counsel II, on 05/11/2026, per the signature block included in the filing.

Does the filing indicate active intent or passive investment by CRGI?

The amended Schedule 13G identifies a 4.6% position and does not assert activist intent; the filing structure and percentage are consistent with institutional reporting under passive ownership classifications.

How many shares does the filing say are outstanding for GE HealthCare?

The filing references 456,290,143 shares as the number of common shares believed to be outstanding, which is the figure used to calculate the 4.6% stake.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

GE HealthCare Technologies Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

36266G107

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 36266G107

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 21,106,720.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 21,114,633.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

21,114,633.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GE HealthCare Technologies Inc.
(b)	Address of issuer's principal executive offices: 500 W Monroe Street, Chicago, IL 60661, United States of America
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 36266G107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 21,114,633 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 21,114,633 shares or 4.6% of the 456,290,143 shares believed to be outstanding.
(b)	Percent of class: 4.6 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 21,106,720
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 21,114,633
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	05/11/2026